Literature DB >> 19339923

The role of hyperuricemia in vascular disorders.

N Lawrence Edwards1.   

Abstract

PURPOSE OF REVIEW: The role of uric acid as a mediator of vascular damage is not a new idea but has only recently gained widespread acceptance. Uric acid has previously been viewed as a benign solute in serum until it exceeds its saturation level. Others have viewed it as an important antioxidant. These opinions have given way to strong epidemiologic evidence that uric acid elevation may damage endothelial cells and cause significant medical problems. RECENT
FINDINGS: The comorbidities associated with gout include hypertension, renal failure, obesity and diabetes. Multiple large epidemiologic studies cited in this review show that uric acid itself may play an important role in initiating the vascular endothelial dysfunction associated with this cluster of medical problems and ultimately lead to stroke, coronary artery disease and chronic kidney disease. These studies are supported by experiments in animals demonstrating how uric acid can gain entrance into cells and function as a 'pro-oxidant'.
SUMMARY: Uric acid has been long recognized as the cause of gouty arthritis and kidney stones. There is mounting evidence that it may also have an important role in the development of vascular conditions such as coronary heart disease, stroke and kidney disease. These findings have important implications for the way we view asymptomatic hyperuricemia and for future therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339923     DOI: 10.1097/BOR.0b013e3283257b96

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  41 in total

1.  Oxidative damage is present in plasma and circulating neutrophils 4 weeks after a high mountain expedition.

Authors:  Lucrecia Carrera-Quintanar; Miguel Lopez-Fuertes; Vicente Climent; Maria Herranz-Lopez; Vicente Micol; Antoni Pons; Francisco Sogorb; Enrique Roche
Journal:  Eur J Appl Physiol       Date:  2011-12-06       Impact factor: 3.078

Review 2.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  The risk of Parkinson disease associated with urate in a community-based cohort of older adults.

Authors:  S Jain; T G Ton; R M Boudreau; M Yang; E L Thacker; S Studenski; W T Longstreth; E S Strotmeyer; A B Newman
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

4.  Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality.

Authors:  George N Ioannou; Edward J Boyko
Journal:  Atherosclerosis       Date:  2012-10-22       Impact factor: 5.162

5.  Rosehip inhibits xanthine oxidase activity and reduces serum urate levels in a mouse model of hyperuricemia.

Authors:  Hidetomo Kikuchi; Satomi Kogure; Rie Arai; Kouki Saino; Atsuko Ohkubo; Tadashi Tsuda; Katsuyoshi Sunaga
Journal:  Biomed Rep       Date:  2017-04-10

6.  Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.

Authors:  Kazufumi Nagahama; Taku Inoue; Kentaro Kohagura; Kozen Kinjo; Yusuke Ohya
Journal:  Hypertens Res       Date:  2014-11-06       Impact factor: 3.872

7.  Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

Authors:  Hirofumi Yano; Yoshifuru Tamura; Kana Kobayashi; Masayuki Tanemoto; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

Review 8.  Vascular endothelium dysfunction: a conservative target in metabolic disorders.

Authors:  Shalini Jamwal; Saurabh Sharma
Journal:  Inflamm Res       Date:  2018-01-25       Impact factor: 4.575

9.  Blood lipid profile and BMI-Z-score in adolescents with hyperuricemia.

Authors:  M J Stelmach; N Wasilewska; L I Wicklund-Liland; A Wasilewska
Journal:  Ir J Med Sci       Date:  2014-05-30       Impact factor: 1.568

10.  What lies behind serum urate concentration? Insights from genetic and genomic studies.

Authors:  Kimiyoshi Ichida
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.